Bivalirudin Kensington Pharma

Bivalirudin Kensington Pharma is an anticoagulant used to prevent blood clots during procedures. This intravenous medication is manufactured by Kensington Pharma Ltd in the EU.

Bivalirudin is primarily used to prevent blood clots in patients undergoing certain medical procedures, such as angioplasty or heart surgery. It works by inhibiting the action of thrombin, a key enzyme in blood clot formation. This medication is often used in situations where other anticoagulants may not be suitable.

Common effects of Bivalirudin may include bleeding at the injection site or bruising. Some patients may experience nausea or dizziness. Severe allergic reactions are rare but possible. Always consult a healthcare provider for any concerns.

Bivalirudin should be handled with care to avoid contamination. It is important to monitor for signs of bleeding or unusual bruising. Patients with a history of bleeding disorders or recent surgery should use this medication under close medical supervision.

Bivalirudin may interact with other anticoagulants, antiplatelet drugs, or medications that affect blood clotting. Alcohol and certain supplements may also influence its effectiveness. Always inform your healthcare provider about all medications you are taking.